The diffuse neuroendocrine system: Peptides,amines,placodes and the APUD theory.
Progr Brain Res 1986;68: 25–31.
Murphy, DLet al. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter.
J Neurochem 1993;60: 2319–2322.
The human platelet. A disgnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders.
Arch General Psychiatry 1977;34: 509–516.
4.Da Prada, M,
Launay, JMet al. Platelets as a model for neurones? Experentia 1988;44: 115–126.
Van Oudenhove, Tet al. Dopamine increases platelet intracellular calcium in bipolar disorder and controls.
Int Clin Pharmacol 1994;9: 291–293.
The platelet as a peripheral marker in psychiatric illness.
Hum Psychopharmacol 2001;16: 229–236.
Fundamentals of Psychopharmacology. Chichester: John Wiley, 1992.
Immunological research in clinical psychiatry: report on the consensus debate during the 7th expert meeting on psychiatry and immunology.
Mol Psychiatry 2002;7: 822–826.
Daniell, LCet al. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders.
Arch General Psychiatry 1989;46: 632–638.
Javors, MAet al. Calcium function in affective disorders and healthy controls.
Biol Psychiatry 1988;23: 367–376.
Elevated platelet intracellular calcium concentration in bipolar depression.
Biol Psychiatry 1991;29: 441–450.
Van Oudenhove, T,
The platelet intracellular calcium response to serotonin is augmented in bipolar manic and depressed patients.
Hum Psychopharmacol Clin Exp 1995;10: 189–193.
Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients.
Am J Psychiatry 1992;149: 118–120.
Li, PPet al. High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder.
Am J Psychiatry 1997;154: 976–982.
Superiority of lithium over verapamil in mania: a randomised controlled single blind trial.
J Clin Psychiatry 1996;57: 543–546.
Effects of lithium on platelet ionic intracellular calcium concentration in patients with bipolar (manic-depressive) disorder and healthy controls.
Life Sci 1990;46: 1175–1180.
Lithium blocks 45Ca2+ uptake into platelets in bipolar disorder and controls.
Clin Neuropharmacol, 1996;19: 48–51.
Increased serotonin 2 receptor binding as measured by 3H-LSD binding in blood platelets of depressed patients.
Life Sci 1989;44: 725–734.
Serotonin 2 receptor binding in blood platelets of schizophrenic patients.
Psychiatr Res 1993;47: 111–119.
Chudzik, Jet al. Effects of serotonin reuptske inhibitors on platelet serotonin parameters in major depressive disorder.
Biol Psychiatry 1997;41: 184–190.
Blumenfeld, Bet al. Increased serotonin 5HT2 receptor binding on blood platelets of suicidal men.
Psychopharmacol (Berl) 1990;100: 165–167.
The Galway study of panic disorder II. Changes in some peripheral markers of noradrenergic and serotonergic function in DSM III-R panic disorder.
J Affect Disord 1992;26: 89–99.
Further characterization of the inhibition of platelet aggregation by a plasma factor(s) in unmedicated unipolar depressed patients.
J Affect Disord 1995;33: 227–231.
Ravindran, Aet al. Platelet serotonergic indices in major depression: up-regulation of 5HT2A receptors unchanged by antidepressant treatment.
Psychiatr Res 1997;66: 73–85.
Arnulf, Iet al. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
Clin Pharmacol Therap 1999;66: 617–624.
The current status of the platelet 5-HT(2A) receptor in depression.
J Affect Disord 2000;57: 13–24.
Serotonin-2 receptor-mediated intraplatelet calcium mobilization in affective disorders: relevance to the pathophysiology of depression.
Hokkaido Igaku Zasshi 1993;68: 325–336.
Takahashi, Ket al. Serotonin but not norepinephrine induced calcium mobilization of platelets is enhanced in affective disorders.
Psychopharmacol 1992;106: 311–314.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J Biol Chem 1985;260: 3440–3450.
Augmented platelet calcium uptake in response to serotonin stimulation in patients with major depression measured using Mn2+ influx and 45Ca2+ uptake.
Life Sci 2000;66: 425–431.
Serotonin-induced platelet intracellular Ca2+ responses in untreated depressed patients and imipramine responders in remission.
Biol Psychiatry 1999;45: 1042–1048.
Platelet cytosolic calcium responses to serotonin in depressed patients and controls: relationship to symptomatology and medication.
Biol Psychiatry 1998;43: 327–334.
Serotonin-induced platelet intracellular calcium mobilization in depressed patients.
Psychopharmacol (Berl) 1994;113: 322–327.
Treatment response in depressed patients with enhanced Ca mobilization stimulated by serotonin.
Neuropsychopharmacology 2000;23: 690–696.
Is there a relationship between baseline and treatment-associated changes in [3H]-IMI platelet binding and clinical response in depression? Neuropsychopharmacology 1996;14: 47–53.
San Martino, O,
Grupo de, F.
Pretreatment platelet 5HT concentration predicts the short term response to paroxetine in major depression.
Biol Psychiatry 1999;46: 518–524.
The effect of citalopram treatment on platelet serotonin function in panic disorders.
Int Clin Psychopharmacol 2000;15: 83–91.
Platelet activation in depression and effects of sertraline treatment: an open label study.
Am J Psychiatry 2000;157: 1006–1008.
Manatunga, Aet al. Platelet reactivity in depressed patients treated with paroxetine.
Arch General Psychiatry 2000;57: 875–882.
Cytoplasmic calcium oscillations: a two pool model.
Cell Calcium 1991;12: 63–72.
Serotonin-induced increases in platelet cytosolic calcium in depressives, schizophrenic, and substance abuse patients.
Biol Psychiatry 1996;39: 708–713.
Tamiya, Set al. Serotonin-induced platelet calcium mobilisation is enhanced in bulimia nervosa but not anorexia nervosa.
Biol Psychiatry 1995;38: 274–276.
The platelet intracellular calcium response to serotonin in subsyndromal depression.
Int Clin Psychopharmacol 1998;13: 107–110.
Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey.
J Affect Disord 1997;45: 19–30.
Correlations for serotonin levels and measures of mood in a nonclinical sample.
Psychol Rep 2000;87: 707–716.
Serotonin-induced platelet intracellular calcium mobilization in various psychiatric disorders: is it specific to bipolar disorder? J Affect Disord 2001;64: 291–296.
Enhanced calcium response to serotonin in platelets from patients with affective disorders.
J Psychiatry Neurosci 1996;21: 321–324.
Platelet intracellular calcium in patients with recurrent affective disorders.
Psychopharmacology (Berl) 1994;114: 375–381.
The platelet intracellular calcium response to serotonin and thrombin in patients with panic disorder.
Eur Neuropsychopharmacol 1999;9: 107–110.
Gorodinskii, AIet al. Sites of high affinity binding of L-[3H]-glutamic acid in human platelets. New type of platelet receptors? Biokimiya 1988;53: 848–852.
Pleasure, DEet al. N-methyl-D-aspartate receptors expressed in a non-neuronal cell line mediate subunit-specific increases in free intracellular calcium.
J Biol Chem 1997;272: 647–656.
The human platelet as a model for the glutamatergic neuron: Platelet uptake of 1-glutamate.
J Neurochem 1981;36: 1067–1076.
Schmid- Burgk, Wet al. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.
Neurosci Lett 1980;20: 379–382.
Slusher, BSet al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains Arch General Psychiatry 1995;52: 829–836.
Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia.
Int Clin Psychopharmacol 1999;14: 119–122.
The specificity of the platelet glutamate receptor supersensitivity in psychotic disorders.
Life Sci 2000;66: 2427–2432.
Platelet glutamate supersensitivity in depression.
Int J Neuropsychopharmacol 2000;3: S112.
4-amino[1,2,4]triazolo[4 3a] quinoxalines: a novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
J Med Chem 1990;33: 2240–2254.
Adenosine: The prototypic neuromodulator.
Neurochem Inter, 1989;14: 249–264.
Antidepressant drugs potentiate suppression by adenosine of neuronal firing in rat cerebral cortex.
Neurosci Lett, 1979;11: 93–97.
Trazodone, a non-tricyclic antidepressant, is an inhibitor of adenosine deaminease.
Res Commum Chem Pathol Pharmacol 1985;47: 149–152.
Adenosine mechanisms are not affected by antidepressant concentrations of desipramine.
J Pharm Pharmacol, 1984;36: 846–848.
Chronic in vivo treatment with desmethylimipramine and mianserin does not alter adenosine A-1 radioligand binding in rat cortex.
Neurosci Lett 1983;35: 47–51.
Blunted adenosine A2a receptor function in platelets in patients with major depression.
Eur Neuropsychopharmacol 2001;11: 183–186.